View Author
patient group leukemia t-all study lymphoblastic leukemia treatment target childhood rearrangement lymphoblastic children cancer paediatric disease level therapy fication precursor b-all result glucocorticoid trial research relapse precursor oncology point blood germany analysis b-all strati mrd levels diagnosis mrd-based detection european outcome protocol glucocorticoid therapy response sensitivity receptor paediatric oncology sample figure mrd-based strati fication table lymphoblastic leukaemia austria prognostic time points number t-cell t-all patients frequency van dongen jj identi mrd-hr information multicentric identi fied strati fied difference mrd-sr italy follow-up survival enrollment van wering glucocorticoid receptor gene value infant europe interventional mrd-ir randomised aieop-bfm prognostic value type 1 patients
6 Most Recent Publications
|
Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: Results of the AIEOP-BFM-ALL 2000 study
(Article)
Schrappe, M. Valsecchi, M.G. Reiter, A. Basso, G. Klingebiel, T. Messina, C. Ratei, R. Cazzaniga, G. Koehler, R. Locatelli, F. Schäfer, B.W. Aricò, M. Bartram, C.R. Welte, K. Dongen, J.J.M. van Gadner, H. Biondi, A. Conter, V. Schrauder, A. Panzer-Grümayer, R. Möricke, A. Parasole, R. Zimmermann, M. Dworzak, M.N. Buldini, B. |
2011-08-25
|
|
Imperative of continual support by the European Community for future advances in paediatric oncology in Europe: Meeting report of the EC-funded science-communication project DIRECT "Overcoming Cancer with Research"
(Article)
Tallen, G. Dworzak, M.N. Creutzig, U. Gadner, H. Masera, G. Schrappe, M. Biondi, A. Vassal, G. Pieters, R. Jazbec, J. Morland, B. |
2009-12-01
|
|
Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia
(Article)
Flohr, T. Schrauder, A. Sutton, R. Koehler, R. Zimmermann, M. Valsecchi, M.G. Gadner, H. Masera, G. Schrappe, M. Dongen, J.J.M. van Biondi, A. Bartram, C.R. Cazzaniga, G. Panzer-Grümayer, R. Velden, V.H.J. van der Fischer, S. Stanulla, M. Basso, G. Niggli, F. Schäfer, B.W. |
2008-04-01
|
|
Glucocorticoids in the treatment of children with acute lymphoblastic leukemia and Hodgkin's disease: A pilot study on the adverse psychological reactions and possible associations with neurobiological, endocrine, and genetic markers
(Article)
Felder-Puig, R. Scherzer, C. Steinberger, K. Nasel, C. Gadner, H. Topf, R. Dworzak, M.N. Baumgartner, M. Ortner, M. Aschenbrenner, C. Bieglmayer, C. Voigtländer, T. Panzer-Grümayer, E.R. Tissing, W.J.E. Koper, J.W. |
2007-12-01
|
|
Acute lymphoblastic leukemia with t(4;11) in children 1 year and older: The 'big sister' of the infant disease?
(Article)
Mann, G. Cazzaniga, G. Gadner, H. Dongen, J.J.M. van Panzer-Grümayer, E.R. Velden, V.H.J. van der Flohr, T. Csinady, E. Paganin, M. Schrauder, A. Dohnal, A.M. Schrappe, M. Biondi, A. |
2007-04-01
|
|
Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL
(Article)
Willemse, M.J. Hop, W.C.J. Gadner, H. Seriu, T. Hettinger, K. Aniello, E. d' Panzer-Grumayer, E.R. Biondi, A. Dongen, J.J.M. van Schrappe, M. Kamps, W.A. Bartram, C.R. Masera, G. Riehm, H. |
2002-01-01
|